Ives Jeffrey L.
- SEC CIK
- 0001614096
No open-market purchases or sales filed in the past year.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- TVRD Tvardi Therapeutics, Inc.Directoras of Jun 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ives Jeffrey L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ABOS Acumen Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2023 (view filing) | Aug 17 | 1 day | Ives Jeffrey L.Director | SSale | −41.9K | $6.49 | −$272.3K | −100.0%0 after | 2 lots10b5-1 |
TVRD Tvardi Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2022 (view filing) | Jul 15 | 4 days | Ives Jeffrey L.Director | SSale | −3.60K | $9.05 | −$32.6K | −18.9%15.5K after | |
| Nov 16, 2021 (view filing) | Nov 12 | 4 days | Ives Jeffrey L.Director | SSale | −8.18K | $16.04 | −$131.2K | −53.2%7.20K after |